Impact of routine angiographic follow-up after percutaneous coronary intervention with drug-eluting stents in the SPIRIT III randomized trial at three years

American Journal of Cardiology

Volumn 110, Issue 1, 2012, Pages 21-29

  Lansky, Alexandra J ^a   Brar, Somjot S ^b   Yaqub, Manejeh ^c   Sood, Poornima ^c   Applegate, Robert J ^d   Lazar, Dana ^a   Jankovic, Ivana ^a   Hermiller, James B ^e   Koo, Kai ^c   Sudhir, Krishnankutty ^c   Stone, Gregg W ^f  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KAISER PERMANENTE MEDICAL CENTER   (United States)

^c ABBOTT VASCULAR   (United States)

^d WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^e St Vincent s Heart Center of Indiana   (United States)

^f NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS; PACLITAXEL;

ADULT; ANGIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEFT CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RIGHT CORONARY ARTERY; SIDE EFFECT; SINGLE BLIND PROCEDURE; SURVIVAL;

ANGIOPLASTY, BALLOON, CORONARY; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PACLITAXEL; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; REPRODUCIBILITY OF RESULTS; SINGLE-BLIND METHOD; SIROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84862280653     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.02.040     Document Type: Article

References (17)

1. A. Gruntzig Transluminal dilatation of coronary-artery stenosis Lancet 1 1978 263
2. A.R. Gruentzig, S.B. King, M. Schlumpf, W. Siegenthaler Long-term follow-up after percutaneous transluminal coronary angioplasty The early Zurich experience N Engl J Med 316 1987 1127 1132
3. S.J. Park, K.H. Kim, I.Y. Oh, D.H. Shin, K.I. Park, M.K. Seo, J.W. Chung, K.W. Park, H.Y. Lee, H.J. Kang, B.K. Koo, T.J. Youn, H.S. Kim Comparison of plain balloon and cutting balloon angioplasty for the treatment of restenosis with drug-eluting stents vs bare metal stents Circ J 74 2010 1837 1845
4. I. Porto, F. Burzotta, A. Parma, C. Pristipino, A. Manzoli, F. Belloni, G. Sardella, S. Rigattieri, A. Danesi, P. Mazzarotto, F. Summaria, E. Romagnoli, F. Prati, C. Trani, F. Crea Angiographic predictors of recurrent stent thrombosis (from the Outcome of PCI for stent-ThrombosIs MultIcentre STudy [OPTIMIST]) Am J Cardiol 105 2010 1710 1715
5. J.M. Stolker, K.F. Kennedy, J.B. Lindsey, S.P. Marso, M.J. Pencina, D.E. Cutlip, L. Mauri, N.S. Kleiman, D.J. Cohen EVENT Investigators Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registry Circ Cardiovasc Interv 3 2010 327 334
6. E. Di Lorenzo, R. Sauro, A. Varricchio, M. Capasso, T. Lanzillo, F. Manganelli, C. Mariello, F. Siano, M.R. Pagliuca, G. Stanco, G. Rosato, G. De Luca Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angiOplasty (PASEO) randomized trial Am Heart J 158 suppl 2009 e43 e50
7. L. Mauri, T.S. Silbaugh, P. Garg, R.E. Wolf, K. Zelevinsky, A. Lovett, M.R. Varma, Z. Zhou, S.L. Normand Drug-eluting or bare-metal stents for acute myocardial infarction N Engl J Med 359 2008 1330 1342
8. J.W. Moses, M.B. Leon, J.J. Popma, P.J. Fitzgerald, D.R. Holmes, C. O'Shaughnessy, R.P. Caputo, D.J. Kereiakes, D.O. Williams, P.S. Teirstein, J.L. Jaeger, R.E. Kuntz SIRIUS Investigators Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323
9. S.B. Pandya, Y.H. Kim, S.N. Meyers, C.J. Davidson, J.D. Flaherty, D.W. Park, A. Mediratta, K. Pieper, E. Reyes, R.O. Bonow, S.J. Park, N. Beohar Drug-eluting versus bare-metal stents in unprotected left main coronary artery stenosis a meta-analysis JACC Cardiovasc Interv 3 2010 602 611
10. I.M. Singh, S.J. Filby, F. El Sakr, E.Z. Gorodeski, A.M. Lincoff, S.G. Ellis, M.H. Shishehbor Drug-eluting stents versus bare-metal stents for treatment of bare-metal in-stent restenosis Catheter Cardiovasc Interv 76 2010 257 262
11. G.W. Stone, S.G. Ellis, D.A. Cox, J. Hermiller, C. O'Shaughnessy, J.T. Mann, M. Turco, R. Caputo, P. Bergin, J. Greenberg, J.J. Popma, M.E. Russell TAXUS-IV Investigators A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 2004 221 231
12. G.W. Stone, M. Midei, W. Newman, M. Sanz, J.B. Hermiller, J. Williams, N. Farhat, K.W. Mahaffey, D.E. Cutlip, P.J. Fitzgerald, P. Sood, X. Su, A.J. Lansky SPIRIT III Investigators Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial jama 299 2008 1903 1913
13. J.L. Chen, Y.J. Yang, S.B. Qiao, M. Yao, X.W. Qin, B. Xu, H.B. Liu, Y.J. Wu, J.Q. Yuan, J. Chen, S.J. You, J. Dai, J.J. Li, R.L. Gao Comparison of short- and long-term outcomes between Cypher and TAXUS drug-eluting stents for in-stent restenosis Chin Med Sci J 22 2007 5 8
14. C. Spaulding Safety and efficacy update on first-generation drug-eluting stents Am J Cardiol 102 suppl 2008 18J 23J
15. D.E. Cutlip, M.S. Chauhan, D.S. Baim, K.K. Ho, J.J. Popma, J.P. Carrozza, D.J. Cohen, R.E. Kuntz Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials J Am Coll Cardiol 40 2002 2082 2089
16. D.E. Cutlip, S. Windecker, R. Mehran, A. Boam, D.J. Cohen, G.A. van Es, P.G. Steg, M.A. Morel, L. Mauri, P. Vranckx, E. McFadden, A. Lansky, M. Hamon, M.W. Krucoff, P.W. Serruys Academic Research Consortium Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
17. D.S. Pinto, G.W. Stone, S.G. Ellis, D.A. Cox, J. Hermiller, C. O'Shaughnessy, J.T. Mann, R. Mehran, Y. Na, M. Torco, R. Caputo, J.J. Popma, D.E. Cutlip, M.E. Russell, D.J. Cohen TAXUS-IV Investigators Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial J Am Coll Cardiol 48 2006 32 36